Companies: 10,795·Total market cap: $144.5T
GelStat Corporation

GelStat Corporation

GSACOTCHealthcare● Active
$0.00
+$0.00(+50.00%)
Market Cap$185394
P/E Ratio
52W High$0.0005
52W Low$0.0002

GelStat Corporation (GSAC) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

GSAC · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$373,000 for FY2024 (fiscal year ending 2024-12-31), down 77.5% year-over-year. Net profit margin was -106.7%. Based on available data, GelStat Corporation has been profitable since at least 2012.

FY2024 Net Income−$373,000▼ -77.5% YoY
Trailing 12M (TTM)−$278,060trailing 4 quarters sum
Net Profit Margin-106.7%−$373,000 ÷ $349,730
YoY Change-77.5%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · GSAC net income history · GSAC profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2024Loss−$373,000▼ 77.5%-106.7%
FY2023Loss−$210,111▲ +72.4%-140.5%
FY2022Loss−$761,000▼ 60.2%-32619.0%
FY2021Loss−$475,000▼ 167.1%-6764.4%
FY2020Loss−$177,838▼ 201.6%-4502.2%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
GelStat Corporation
GelStat CorporationYOU
GSAC
−$373,000-77.5%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

GelStat Corporation (GSAC) reported net income of −$373,000 for FY2024 (fiscal year ending 2024-12-31), down 77.5% year-over-year. The net profit margin was -106.7% — meaning the company kept $-1.07 of every dollar of revenue as profit.

Based on available data, GelStat Corporation has been profitable since at least 2012. Net income reached a peak of $464,102 in FY2012. Data available for 15 fiscal years.

GelStat Corporation's net profit margin was -106.7% for FY2024, based on the latest annual results.

Investors sometimes search for "GelStat Corporation net worth" — the company's market capitalization is a separate figure from GSAC net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

GSAC net income · 4 questions

GelStat Corporation is not currently profitable on an annual basis. The company reported a net loss of $373,000 for FY2024.

is GSAC profitabledoes GSAC make a profitGSAC profitabilityGSAC profitable company

Source: FMP /income-statement · GAAP · GelStat Corporation · GelStat Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026